70 likes | 228 Views
Meaningful Use Workgroup. Paul Tang, Chair George Hripcsak, Co-Chair. April 16, 2014. Meaningful Use Workgroup Members. Chairs Paul Tang, Chair, Palo Alto Medical Center George Hripcsak, Co-Chair, Columbia University Members David Bates , Brigham & Women’s Hospital *
E N D
Meaningful Use Workgroup Paul Tang, Chair George Hripcsak, Co-Chair April 16, 2014
Meaningful Use Workgroup Members Chairs • Paul Tang, Chair, Palo Alto Medical Center • George Hripcsak, Co-Chair, Columbia University Members • David Bates, Brigham & Women’s Hospital* • Christine Bechtel, National Partnership for Women & Families * • Neil Calman, The Institute for Family Health • Art Davidson , Denver Public Health Department * • Paul Egerman , Software Entrepreneur • Marty Fattig, Nemaha County Hospital (NCHNET) • Leslie Kelly Hall, Healthwise • David Lansky, Pacific Business Group on Health • Deven McGraw, Center for Democracy & Technology • Marc Overhage, Siemens Healthcare • Patricia Sengstack, Bon Secours Health Systems • Charlene Underwood, Siemens * • Michael H. Zaroukian, Sparrow Health System • Amy Zimmerman, Rhode Island Department of Health and Human Services Federal Ex-Officios • Joe Francis, MD, Veterans Administration • Marty Rice, HRSA • Greg Pace, Social Security Administration • Robert Tagalicod, CMS/HHS * Subgroup Leads
Agenda • Listening session planning
Session I: May 20, 2014 • 3 hours sessions • 2 panels • 5 minutes per speaker with ample time for panel discussions • Panel 1: Providers working towards stage 2 (20 minute presentation/20 discussion) • Small/rural • Group practice • Health system • Provider association • Consumer • Panel 2: Hospitals working towards stage 2 (20 minute presentation/20 discussion) • Small/rural hospital • Medium community hospital • Large hospital • Health system • Hospital association
Session II: May 27, 2014 • Panel 3: Accountable Care Arrangements • Purchasers • ACOs • Panel 4: Vendors • Small vendor • Large vendor • Hospital vendor • Vendor association • Data intermediary? Open source?
Potential Questions • What has been your experience with stage 2? What success factors have you identified? • What should be taken into account as we look to stage 3? • What benefits have you achieved from working towards achievement of meaningful use?